ドラッグデリバリーの放出制御市場：放出メカニズム、技術、用途別-2024-2030年の世界予測

ドラッグデリバリーの放出制御市場規模は2023年に430億7,000万米ドルと推定され、2024年には467億米ドルに達し、CAGR 9.17％で2030年には796億2,000万米ドルに達すると予測されます。

放出制御ドラッグデリバリーとは、薬剤の有効成分を予測可能かつ制御可能な速度で放出するシステムを指します。ドラッグデリバリーへのこのアプローチは、血流中の薬剤レベルを安定させ、投与回数を減らし、患者のコンプライアンスを向上させることができます。放出制御ドラッグデリバリーの市場は、様々な用途や最終用途のシナリオにおいて、これらの目的を達成する製品や技術によって定義されます。放出制御薬物デリバリーの用途は、糖尿病、心血管疾患、中枢神経系疾患、疼痛管理、腫瘍学など、複数の治療分野に及んでいます。放出制御ドラッグデリバリー市場の成長に影響を与える課題には、新たなドラッグデリバリーシステムの開発に伴う高コストと、特定の薬剤に対する放出制御ドラッグデリバリーシステムの処方における技術的課題が含まれます。市場は、個々の患者のニーズに合わせたドラッグ・デリバリー・システムの構築を可能にする精密医療アプローチの進歩を目の当たりにしています。さらに、ヘルスケアインフラの拡大と医薬品へのアクセスの向上が放出制御技術に新たな機会をもたらしている新興市場にも、明らかに勢いがあります。さらに、製薬企業とドラッグデリバリー技術企業との戦略的パートナーシップにより、イノベーションが促進され、洗練されたより効果的なドラッグデリバリー機構が開発されることで、情勢は再構築されつつあります。

放出メカニズム：強固な化学的活性化システム開発のための研究開発活動の増加

活性化調節型ドラッグデリバリーシステムは、磁場、超音波、pH変化、酵素などの外部または内部のトリガーによる刺激で薬剤を放出するように設計されています。これらのシステムは、薬物の放出プロファイルを正確に制御することができ、特に体内の特定の部位を標的として、全身的な副作用を軽減するのに有益です。化学的に活性化されたシステムは、特定の酵素の存在やpHレベルの変化など、薬物放出の引き金となる特定の化学反応に依存しています。これらのシステムは、消化管の様々な部位で活性化するように調整できるため、消化管治療に適しています。フィードバック制御システムは、生物学的または化学的反応を利用して薬物放出を制御します。薬物放出は生理学的要求に基づいてリアルタイムで調整され、個別化医療を促進します。このようなシステムには通常、薬物送達デバイスと統合されたセンサーが含まれます。マイクロリザーバーシステムは、薬物を含む複数の小さなコンパートメント（リザーバー）で構成され、制御された間隔または特定のトリガーで放出されます。このアプローチは、異なる放出プロファイルを持つ複数のドラッグデリバリーを可能にし、複雑な投薬レジメンに有用です。ポリマーベースのドラッグデリバリーシステムは、生分解性ポリマーを利用して薬物を封入し、ポリマーが分解するにつれてゆっくりと薬物を放出します。これらのシステムは放出期間が長く、慢性疾患に適しています。

技術治療指数を高め、副作用を軽減するための標的デリバリーの統合

コアセルベーションは、コロイド溶液をポリマーが豊富なコアセルベート相とポリマーが乏しい上澄み液という2つの異なる液相に分離するプロセスです。この技術は、環境劣化から薬剤を保護し、放出を制御するために薬剤をカプセル化するために使用されます。有効成分が劣化に敏感で、保護バリアが必要な場合に優先的に使用されます。インプラントは、長期間にわたって治療薬を作用部位に直接放出するように設計された医療機器です。腫瘍学やホルモン補充療法など、局所的で持続的なドラッグデリバリーが望まれる場合に使用されます。マイクロカプセル化では、小さな粒子や液滴をコーティングでカプセル化し、小さなカプセルに有用な特性を持たせる。ターゲットデリバリーは、活性薬剤を体内の特定の細胞や組織に誘導することで、治療指数を高め、副作用を軽減することを目的としています。この技術は、がん治療のように全身への薬物曝露を最小限に抑えつつ、疾患部位に高濃度の薬物が必要な場合に好まれます。経皮ドラッグデリバリーシステム（TDDS）は皮膚から薬物を投与するもので、経口や注射に代わる非侵襲的で便利な方法です。TDDSは通常、継続的な薬物投与が有利な慢性疾患管理に選択されます。Wurster法は流動床コーティングのサブセットで、薬剤の放出制御を達成するために顆粒、ペレット、粒子をコーティングするために医薬品で広く使用されています。この方法は、均一なコーティングと放出動態の精密な制御を必要とする薬剤に適しています。

応用例慢性疾患管理における注射用放出制御型ドラッグデリバリーシステムへの嗜好の高まり

ドラッグ溶出ステントは、心臓病学で使用される放出制御型薬物デリバリーの顕著な実施例です。ステントの構造に薬剤を組み込むことで、これらのデバイスは血管形成術の際に狭窄した冠動脈に留置されます。薬剤は時間をかけてゆっくりと放出され、処置後の動脈の再狭窄（再狭窄）を防ぐ。輸液ポンプは、栄養剤や薬剤を含む輸液を患者の体内に制御された方法で送り込むために設計された医療機器です。これらのポンプは、病院、介護施設、在宅介護の患者など、さまざまなヘルスケア環境で使用することができます。ドラッグデリバリーのタイミング、速度、時間を制御できることは、血流中の治療薬レベルを維持するのに役立ち、これは化学療法、疼痛管理、抗生物質の投与などの治療に不可欠です。注射可能な放出制御システムは、特に全身効果や標的治療のためのドラッグデリバリーに高度なアプローチを提供します。これらのシステムでは、カプセル化された薬剤粒子や生分解性ポリマーが使用されることが多く、時間の経過とともに分解され、所定の速度で薬剤が放出されます。定量吸入器は、特定量の薬剤を肺に供給するように設計された装置で、喘息やCOPDなどの呼吸器疾患の治療によく用いられます。MDIの放出制御機構は、同じ薬剤の全身投与と比較して、正確な投与、迅速な作用発現、全身的な副作用の軽減を保証することにより、患者の状態を効果的に管理することを可能にします。経口ドラッグデリバリーは、最も一般的な放出制御技術の一つです。錠剤、カプセル剤、フィルム剤など様々な製剤があり、消化器官から薬物が放出・吸収される速度を制御します。経皮パッチと眼用パッチは、ユニークな放出制御型ドラッグデリバリーシステム分野です。経皮パッチは皮膚を通して薬物を投与するため、長期間にわたって安定した薬物放出が可能で、ピーク時の変動を最小限に抑え、患者の快適性を向上させる。

地域別の洞察

南北アメリカ、特に北米の放出制御型ドラッグデリバリー市場は、主要製薬企業の存在と高度なヘルスケアインフラにより確立されています。米国は、新規ドラッグデリバリーシステムに対するFDAの支援と、長期投与が必要な慢性疾患の有病率の高さにより、市場で重要な地位を占めています。欧州は、欧州医薬品庁（EMA）が管理する強力な規制の枠組みにより、ドラッグデリバリーの放出制御市場で大きなシェアを占めています。同市場は、政府のヘルスケア政策や特許の崖によるジェネリック医薬品の台頭などの恩恵を受けています。中東・アフリカは、経済発展、ヘルスケア・インフラへの投資、高度な治療オプションへのアクセスの増加により、潜在的な成長を示しています。アジア太平洋は、中国やインドなどの国々における製薬産業の拡大とヘルスケア支出の増加により、放出制御ドラッグデリバリー分野で急速な成長が見込まれています。多くの患者が抱えるアンメット・メディカル・ニーズへの対応にますます注目が集まっています。ジェネリック医薬品の使用促進における国内外企業間の提携や政府の支援は、この地域における成長機会を提供します。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、ドラッグデリバリーの放出制御市場の評価において極めて重要です。事業戦略や製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析は、ドラッグデリバリーの放出制御市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度：有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化：新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報：市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション：将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています：

1.ドラッグデリバリーの放出制御市場の市場規模および予測は？

2.ドラッグデリバリーの放出制御市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か？

3.ドラッグデリバリーの放出制御市場の技術動向と規制枠組みは？

4.ドラッグデリバリーの放出制御市場における主要ベンダーの市場シェアは？

5.ドラッグデリバリーの放出制御市場への参入に適した形態や戦略的手段は？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 乳幼児および高齢者層における放出制御製剤のニーズ増加
    • ハイドロゲルと浸透圧制御ドラッグデリバリーシステムの採用増加
    • さまざまな病気を制御するために治療効果を高め、薬物の毒性を減らす必要がある
  • 抑制要因
    • ドラッグデリバリーの放出制御システムの複雑な製造プロセス
  • 機会
    • 先端医療におけるナノテクノロジーの潜在的発展/放出制御型ドラッグデリバリーシステムのための製剤
    • 制御放出ドラッグデリバリーシステムの進歩
  • 課題
    • 制御薬物放出製剤の潜在的な限界
• 市場セグメンテーション分析
  • 放出メカニズム：化学的に活性化された堅牢なシステムの開発に向けた研究開発活動の強化
  • 技術：治療指数を高め、副作用を軽減するための標的送達の統合
  • 応用：慢性疾患管理における注射可能な徐放性ドラッグデリバリーシステムの好感度の高まり
• 市場動向分析
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制枠組みの分析
• 顧客のカスタマイズ

第6章 ドラッグデリバリーの放出制御市場リリースメカニズム別

• 活性化変調ドラッグデリバリーシステム
• 化学的に活性化
• フィードバック制御ドラッグデリバリーシステム
• マイクロリザーバーパーティション制御ドラッグデリバリーシステム
• ポリマーベースのシステム

第7章 ドラッグデリバリーの放出制御市場：技術別

• コアセルベーション
• インプラント
• マイクロカプセル化
• ターゲット配信
• 経皮
• ウルスターテクニック

第8章 ドラッグデリバリーの放出制御市場：用途別

• 薬剤溶出ステント
• 輸液ポンプ
• 注射可能
• 定量吸入器
• 経口制御ドラッグデリバリーシステム
• 経皮パッチと眼科用パッチ

第9章 南北アメリカのドラッグデリバリーの放出制御市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域のドラッグデリバリーの放出制御市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカのドラッグデリバリーの放出制御市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス、2023
• 競合シナリオ分析
  • DelSiTech、シリカベースのドラッグデリバリー技術プラットフォームの発展に向けて1,000万ユーロの資金調達ラウンドの完了を発表
  • Chiesi Global Rare DiseasesとAliada Therapeuticsが提携し、ドラッグデリバリーのための血液脳関門通過プラットフォーム技術を発展させる

第13章 競合ポートフォリオ

• 主要企業プロファイル
• 主要製品ポートフォリオ

LIST OF FIGURES

• FIGURE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET RESEARCH PROCESS
• FIGURE 2. CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
• FIGURE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. CONTROLLED RELEASE DRUG DELIVERY MARKET DYNAMICS
• FIGURE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2030 (%)
• FIGURE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 13. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 14. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 15. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 16. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 17. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 18. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 19. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 21. CONTROLLED RELEASE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 22. CONTROLLED RELEASE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. CONTROLLED RELEASE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2018-2023 (USD MILLION)
• TABLE 4. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, 2024-2030 (USD MILLION)
• TABLE 5. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 6. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 7. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 8. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 9. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 10. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 11. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 12. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 13. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 14. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDRODYNAMIC PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 15. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 16. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MAGNETICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 17. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 18. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MECHANICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 19. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 20. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY OSMOTIC PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 21. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 22. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY VAPOR PRESSURE ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 23. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 24. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 25. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 26. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 27. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 28. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ENZYME ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 29. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 30. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY HYDROLYSIS ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 31. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2018-2023 (USD MILLION)
• TABLE 32. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY PH ACTIVATED, BY REGION, 2024-2030 (USD MILLION)
• TABLE 33. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 34. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY FEEDBACK REGULATED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 35. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 36. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO RESERVOIR PARTITION CONTROLLED DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 37. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 38. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY POLYMER BASED SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 39. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 40. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 41. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 42. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COACERVATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 43. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 44. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY IMPLANTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 45. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2018-2023 (USD MILLION)
• TABLE 46. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY MICRO ENCAPSULATION, BY REGION, 2024-2030 (USD MILLION)
• TABLE 47. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2018-2023 (USD MILLION)
• TABLE 48. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TARGETED DELIVERY, BY REGION, 2024-2030 (USD MILLION)
• TABLE 49. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2023 (USD MILLION)
• TABLE 50. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL, BY REGION, 2024-2030 (USD MILLION)
• TABLE 51. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 52. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY WURSTER TECHNIQUE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 53. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 54. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 55. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 56. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY DRUG ELUTING STENTS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 57. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 58. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INFUSION PUMPS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 59. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2023 (USD MILLION)
• TABLE 60. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY INJECTABLE, BY REGION, 2024-2030 (USD MILLION)
• TABLE 61. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 62. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY METERED DOSE INHALERS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 63. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2018-2023 (USD MILLION)
• TABLE 64. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ORAL CONTROLLED-DRUG DELIVERY SYSTEMS, BY REGION, 2024-2030 (USD MILLION)
• TABLE 65. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2018-2023 (USD MILLION)
• TABLE 66. GLOBAL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TRANSDERMAL & OCULAR PATCHES, BY REGION, 2024-2030 (USD MILLION)
• TABLE 67. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 68. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 69. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 70. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 71. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 72. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 73. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 74. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 75. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 76. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 77. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 78. AMERICAS CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 79. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 80. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 81. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 82. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 83. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 84. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 85. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 86. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 87. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 88. ARGENTINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 89. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 90. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 91. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 92. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 93. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 94. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 95. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 96. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 97. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 98. BRAZIL CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 99. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 100. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 101. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 102. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 103. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 104. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 105. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 106. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 107. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 108. CANADA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 109. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 110. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 111. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 112. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 113. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 114. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 115. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 116. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 117. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 118. MEXICO CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 119. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 120. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 121. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 122. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 123. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 124. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 125. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 126. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 127. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 128. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 129. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
• TABLE 130. UNITED STATES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
• TABLE 131. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 132. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 133. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 134. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 135. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 136. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 137. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 138. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 139. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 140. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 141. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 142. ASIA-PACIFIC CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 143. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 144. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 145. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 146. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 147. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 148. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 149. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 150. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 151. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 152. AUSTRALIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 153. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 154. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 155. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 156. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 157. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 158. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 159. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 160. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 161. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 162. CHINA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 163. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 164. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 165. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 166. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 167. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 168. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 169. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 170. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 171. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 172. INDIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 173. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 174. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 175. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 176. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 177. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 178. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 179. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 180. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 181. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 182. INDONESIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 183. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 184. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 185. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 186. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 187. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 188. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 189. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 190. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 191. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 192. JAPAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 193. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 194. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 195. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 196. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 197. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 198. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 199. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 200. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 201. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 202. MALAYSIA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 203. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 204. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 205. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 206. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 207. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 208. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 209. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 210. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 211. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 212. PHILIPPINES CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 213. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 214. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 215. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 216. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 217. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 218. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 219. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 220. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 221. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 222. SINGAPORE CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 223. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 224. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 225. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 226. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 227. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 228. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 229. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 230. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 231. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 232. SOUTH KOREA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 233. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 234. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 235. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 236. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 237. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 238. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 239. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 240. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 241. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 242. TAIWAN CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 243. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 244. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 245. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 246. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 247. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 248. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 249. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 250. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 251. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 252. THAILAND CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 253. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 254. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 255. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 256. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 257. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 258. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 259. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 260. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 261. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 262. VIETNAM CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 263. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 264. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 265. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 266. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 267. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 268. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 269. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLION)
• TABLE 270. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2024-2030 (USD MILLION)
• TABLE 271. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
• TABLE 272. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
• TABLE 273. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
• TABLE 274. EUROPE, MIDDLE EAST & AFRICA CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
• TABLE 275. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2018-2023 (USD MILLION)
• TABLE 276. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY RELEASE MECHANISM, 2024-2030 (USD MILLION)
• TABLE 277. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2018-2023 (USD MILLION)
• TABLE 278. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY ACTIVATION-MODULATED DRUG DELIVERY SYSTEMS, 2024-2030 (USD MILLION)
• TABLE 279. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2018-2023 (USD MILLION)
• TABLE 280. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY CHEMICALLY ACTIVATED, 2024-2030 (USD MILLION)
• TABLE 281. DENMARK CONTROLLED RELEASE DRUG DELIVERY MARKET SIZE, BY TECHNOLOGY, 2018-2023 (USD MILLIO

[196 Pages Report] The Controlled Release Drug Delivery Market size was estimated at USD 43.07 billion in 2023 and expected to reach USD 46.70 billion in 2024, at a CAGR 9.17% to reach USD 79.62 billion by 2030.

Controlled-release drug delivery refers to systems that release the active ingredient of a drug at a predictable and controllable rate. This approach to drug delivery ensures a steady level of medication in the bloodstream, reduces the frequency of dosing, and can improve patient compliance. The market for controlled-release drug delivery is defined by products and technologies that accomplish these objectives across various applications and end-use scenarios. Applications for controlled-release drug delivery span multiple therapeutic areas, such as diabetes, cardiovascular diseases, CNS disorders, pain management, and oncology. Challenges affecting the growth of the controlled-release drug delivery market involve High costs associated with developing new drug delivery systems and Technical challenges in formulating controlled-release drug delivery systems for certain drugs. The market is witnessing the advancement of precision medicine approaches that enable the creation of tailored drug delivery systems for individual patient needs. Additionally, there is an apparent momentum in emerging markets where the expansion of healthcare infrastructures and improved access to pharmaceuticals are generating new opportunities for controlled-release technologies. Furthermore, the landscape is being reshaped by strategic partnerships between pharmaceutical enterprises and drug-delivery technology firms, fostering innovation and the development of sophisticated, more effective drug-delivery mechanisms.

Release Mechanism: Increasing R&D activities for development of robust chemically activated system

Activation-modulated drug delivery systems are designed to release the drug upon stimulation by external or internal triggers such as magnetic fields, ultrasound, pH changes, or enzymes. These systems offer precise control over the release profile of the drug and are particularly beneficial in targeting specific sites within the body, reducing systemic side effects. Chemically activated systems rely on specific chemical reactions to trigger drug release, such as the presence of certain enzymes or changes in pH levels. These systems are well-suited for gastrointestinal treatments as they can be tailored to activate in different parts of the GI tract. Feedback regulated systems use biological or chemical responses to control drug release. The drug release is adjusted in real-time based on physiological demand, promoting personalized medicine. Such systems usually involve sensors integrated with drug-delivery devices. Micro reservoir systems consist of multiple tiny compartments (reservoirs) containing the drug, which are released at controlled intervals or upon specific triggers. This approach allows for the delivery of multiple drugs with different release profiles and is useful for complex medication regimens. Polymer-based drug delivery systems utilize biodegradable polymers to encase the drug, releasing it slowly as the polymer degrades. These systems offer prolonged release periods and are well-suited for chronic conditions.

Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects

Coacervation is a process that involves the separation of colloidal solutions into two distinct liquid phases: a polymer-rich coacervate phase and a polymer-poor supernatant. This technology is used for encapsulating drugs to protect them from environmental degradation and to control their release. It is preferentially used when the active ingredient is sensitive to degradation and requires a protective barrier. Implants are medical devices designed to release therapeutic agents directly into the site of action over an extended period. They are employed when localized, continuous drug delivery is desired, such as in oncology or hormone replacement therapies. Microencapsulation involves encapsulating tiny particles or droplets with a coating to give small capsules useful properties. Targeted delivery aims to direct the active drug to specific cells or tissues in the body, thereby increasing the therapeutic index and reducing side effects. This technology is preferred for conditions requiring high drug concentrations at the disease site while minimizing systemic exposure, such as in cancer treatments. Transdermal drug delivery systems (TDDS) administer drugs through the skin, providing a non-invasive and convenient alternative to oral and injectable routes. TDDS is typically chosen for chronic disease management where continuous drug administration is advantageous. The Wurster Technique is a subset of fluidized bed coating used extensively in pharmaceuticals for coating granules, pellets, or particles to achieve a controlled release of the drug. This method is well-suited for drugs that require a uniform coating and precise control over the release kinetics.

Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management

Drug-eluting stents are a remarkable implementation of controlled-release drug delivery used in cardiology. By incorporating medication into the stent's structure, these devices are placed into narrowed, diseased coronary arteries during angioplasty. The drugs are released slowly over time to prevent restenosis, the re-narrowing of the arteries after the procedure. Infusion pumps are medical devices designed to deliver fluids, including nutrients and medications, into a patient's body in a controlled manner. These pumps can be used in a variety of healthcare settings, including hospitals, nursing homes, and even for patients in home care. The ability to control the timing, rate, and duration of delivery helps in maintaining therapeutic drug levels in the bloodstream, which is essential for treatments such as chemotherapy, pain management, and the administration of antibiotics. Injectable controlled release systems offer a sophisticated approach to drug delivery, particularly for systemic effects or targeted therapy. These systems often involve encapsulated drug particles or biodegradable polymers that degrade over time, releasing the drug at a predetermined rate. Metered Dose Inhalers are devices designed to deliver specific amounts of medication to the lungs, commonly used to treat respiratory conditions such as asthma and COPD. The controlled release mechanism in MDIs allows patients to manage their conditions effectively by ensuring precise dosing, rapid onset of action, and reduced systemic side effects compared to systemic administration of the same drugs. Oral controlled-drug delivery systems are one of the most common forms of controlled-release technologies available. They incorporate various formulations such as tablets, capsules, or films that control the rate at which the digestive system releases and absorbs the drug. Transdermal and ocular patches represent a unique controlled-release drug delivery system segment. Transdermal patches administer medication through the skin, allowing for a steady drug release over an extended period, minimizing peak-trough fluctuations and improving patient comfort.

Regional Insights

The controlled-release drug delivery market in the Americas, particularly North America, is well-established due to the presence of key pharmaceutical companies and advanced healthcare infrastructure. The United States holds a significant position in the market, owing to FDA support for novel drug delivery systems and a higher prevalence of chronic diseases, which necessitate prolonged drug administration. Europe holds a substantial share in the controlled release drug delivery market, with a strong regulatory framework governed by the European Medicines Agency (EMA). The market benefits from favorable government healthcare policies and the rise of generics due to patent cliffs. The Middle East and Africa exhibit potential growth due to economic development, investment in healthcare infrastructure, and increasing accessibility to advanced treatment options. Asia-Pacific is expected to experience rapid growth in the controlled-release drug delivery sector due to the expanding pharmaceutical industry and rising healthcare expenditure in countries such as China and India. There is an increasing focus on addressing the unmet medical needs of a large patient population. Partnerships between local and international players and governmental support in promoting generic drug use offer growth opportunities in this region.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Controlled Release Drug Delivery Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Controlled Release Drug Delivery Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Controlled Release Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include Adare Pharma Solutions, Alkermes PLC, AMW GmbH, AstraZeneca PLC, Avantor, Inc., Baxter International Inc., Becton, Dickinson and Company, Biogen Inc., Boehringer Ingelheim International GmbH, Catalent, Inc., Celanese Corporation, Celares GmbH, Coating Place, Inc., Collegium Pharmaceutical, Inc., Colorcon, Inc., Corium, Inc., CURE Pharmaceutical, GlaxoSmithKline PLC, Insulet Corporation, Johnson & Johnson Services, Inc., Lonza Group Ltd., Medtronic PLC, Merck & Co., Inc., Pensatech Pharma GmbH, Pfizer Inc., Seqens, Tandem Diabetes Care, Inc., and Trelleborg AB.

Market Segmentation & Coverage

This research report categorizes the Controlled Release Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Release Mechanism
  • Activation-Modulated Drug Delivery Systems
    • Hydrodynamic Pressure Activated
    • Magnetically Activated
    • Mechanically Activated
    • Osmotic Pressure Activated
    • Vapor Pressure Activated

• Chemically Activated
  • Enzyme Activated
  • Hydrolysis Activated
  • pH Activated

• Feedback Regulated Drug Delivery Systems
• Micro Reservoir Partition Controlled Drug Delivery Systems
• Polymer Based Systems

• Technology
  • Coacervation
  • Implants
  • Micro Encapsulation
  • Targeted Delivery
  • Transdermal
  • Wurster Technique

• Application
  • Drug Eluting Stents
  • Infusion Pumps
  • Injectable
  • Metered Dose Inhalers
  • Oral Controlled-Drug Delivery Systems
  • Transdermal & Ocular Patches

• Region
  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam

• Europe, Middle East & Africa
  • Denmark
  • Egypt
  • Finland
  • France
  • Germany
  • Israel
  • Italy
  • Netherlands
  • Nigeria
  • Norway
  • Poland
  • Qatar
  • Russia
  • Saudi Arabia
  • South Africa
  • Spain
  • Sweden
  • Switzerland
  • Turkey
  • United Arab Emirates
  • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Controlled Release Drug Delivery Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Controlled Release Drug Delivery Market?

3. What are the technology trends and regulatory frameworks in the Controlled Release Drug Delivery Market?

4. What is the market share of the leading vendors in the Controlled Release Drug Delivery Market?

5. Which modes and strategic moves are suitable for entering the Controlled Release Drug Delivery Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increase in Need for Controlled Release Dosage Forms for the Infants and Geriatric Population
    • 5.1.1.2. Rising Adoption of Hydrogel and Osmotic Controlled Drug Delivery System
    • 5.1.1.3. Need to Improve the Therapeutic Benefits, Reduce Drug Toxicity to Control Various Types of Illness
  • 5.1.2. Restraints
    • 5.1.2.1. Complex Manufacturing Process of Controlled Release Drug Delivery System
  • 5.1.3. Opportunities
    • 5.1.3.1. Potential Development of Nanotechnology in Advanced Medicine/Drug Formulations for Controlled-Release Drug Delivery System
    • 5.1.3.2. Advances in Control Release Drug Delivery System
  • 5.1.4. Challenges
    • 5.1.4.1. Potential limitation of controlled drug release formulation
• 5.2. Market Segmentation Analysis
  • 5.2.1. Release Mechanism: Increasing R&D activities for development of robust chemically activated system
  • 5.2.2. Technology: Integration of targeted delivery to increase therapeutic index and reducing side effects
  • 5.2.3. Application: Rising preference for injectable controlled-release drug delivery systems for chronic disease management
• 5.3. Market Trend Analysis
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework Analysis
• 5.9. Client Customization

6. Controlled Release Drug Delivery Market, by Release Mechanism

• 6.1. Introduction
• 6.2. Activation-Modulated Drug Delivery Systems
• 6.3. Chemically Activated
• 6.4. Feedback Regulated Drug Delivery Systems
• 6.5. Micro Reservoir Partition Controlled Drug Delivery Systems
• 6.6. Polymer Based Systems

7. Controlled Release Drug Delivery Market, by Technology

• 7.1. Introduction
• 7.2. Coacervation
• 7.3. Implants
• 7.4. Micro Encapsulation
• 7.5. Targeted Delivery
• 7.6. Transdermal
• 7.7. Wurster Technique

8. Controlled Release Drug Delivery Market, by Application

• 8.1. Introduction
• 8.2. Drug Eluting Stents
• 8.3. Infusion Pumps
• 8.4. Injectable
• 8.5. Metered Dose Inhalers
• 8.6. Oral Controlled-Drug Delivery Systems
• 8.7. Transdermal & Ocular Patches

9. Americas Controlled Release Drug Delivery Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Controlled Release Drug Delivery Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Controlled Release Drug Delivery Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. Market Share Analysis, 2023
• 12.2. FPNV Positioning Matrix, 2023
• 12.3. Competitive Scenario Analysis
  • 12.3.1. DelSiTech Announces Closing of EUR 10 Million Financing Round to Advance its Silica-Based Drug Delivery Technology Platform
  • 12.3.2. Chiesi Global Rare Diseases and Aliada Therapeutics Partner to Advance Blood-Brain Barrier-Crossing Platform Technology for Drug Delivery

13. Competitive Portfolio

• 13.1. Key Company Profiles
• 13.2. Key Product Portfolio